Cyclerion Therapeutics, Inc.
CYCN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,568 | $3,006 | $3,639 | $3,232 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $100 | $525 | $581 | $556 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $397 | $489 | $277 | $437 |
| Total Curr. Assets | $5,065 | $4,020 | $4,497 | $4,225 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $5,350 | $5,350 | $5,350 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5,350 | $0 | $0 | $0 |
| Total NC Assets | $5,350 | $5,350 | $5,350 | $5,350 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10,415 | $9,370 | $9,847 | $9,575 |
| Liabilities | – | – | – | – |
| Payables | $480 | $462 | $483 | $390 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $397 | $338 | $584 | $335 |
| Total Curr. Liab. | $877 | $800 | $1,067 | $725 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $877 | $800 | $1,067 | $725 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$270,221 | -$269,245 | -$268,921 | -$267,492 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $279,759 | $277,815 | $277,701 | $276,342 |
| Total Equity | $9,538 | $8,570 | $8,780 | $8,850 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10,415 | $9,370 | $9,847 | $9,575 |
| Net Debt | -$4,568 | -$3,006 | -$3,639 | -$3,232 |